on October 10, 2025 at 3:13 pm Johnson & Johnson in Talks to Buy Protagonist TherapeuticsLauren ThomasBy aumnamaah@gmail.com / October 10, 2025 The two companies are already codeveloping a treatment for ulcerative colitis.
